Berger, M. G., Lebecque, B., Tassin, T., Dannus, L., Berger, J., Soucal, M., . . . Bourgne, C. (2021). Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells. Nature Portfolio.
Style de citation Chicago (17e éd.)Berger, Marc G., et al. Efficiency of Nilotinib to Target Chronic Phase-chronic Myeloid Leukaemia Primary Mature CD34− and Immature CD34+ cells. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Berger, Marc G., et al. Efficiency of Nilotinib to Target Chronic Phase-chronic Myeloid Leukaemia Primary Mature CD34− and Immature CD34+ cells. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.